Transvaginal mesh litigation has been steadily growing across the country, involving multiple manufacturers and thousands of plaintiffs. For some stuck in legal limbo, a transvaginal mesh settlement loan may help tide them over financially until their case goes to court or reaches a settlement.

Transvaginal mesh was originally designed to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP). The device was used to hold pelvic organs in their proper position after the organs had become weak or stretched through childbirth or the natural aging process. The mesh implants were touted as an alternative to traditional surgical repair, by manufacturers like C.R. Bard, Ethicon and American Medical Systems.

Pelvic mesh complications

However, reports of serious complications associated with vaginal mesh devices have raised significant concerns about their safety and efficacy. Some women experienced mesh erosion and chronic infections from their surgical mesh devices. Persistent abdominal pain, bleeding and infection have been common complaints associated with these devices.

Scores of women have undergone surgery to remove their vaginal mesh. However, surgery has not always been successful and many patients have suffered ongoing problems long after vaginal repair was attempted. For many, these complications have been life-changing, affecting their ability to work, enjoy activities and maintain their personal relationships.

As a result, more than 60,000 women have taken their cases to court, alleging manufacturers of these devices did not provide proper warning about the risks associated with their products. The majority of those cases are now coordinated into multidistrict litigation for the purpose of streamlining early trial proceedings. In U.S. District Court for the Southern District of West Virginia, seven of those MDLs are currently pending against Bard Avaulta, Boston Scientific, Ethicon, American Medical Systems, Coloplast, Neomedic and Cook Medical. The Honorable Judge Joseph Goodwin is overseeing all of that coordinated litigation.

Mesh settlements on the horizon

Earlier this year, American Medical Systems negotiated settlements with many of those plaintiffs, which will cost the company $830 million. C.R. Bard may also be showing signs of heading to the negotiation table, as their parent company Covidien reportedly took a $180 million charge to pay for ongoing transvaginal mesh litigation.

With such a large number of cases pending in transvaginal mesh litigation, it should be no surprise that proceedings are taking a significant amount of time. Whether plaintiffs continue to wait for their day in court or become part of the settlement negotiation process, actual compensation for their injuries may be months or even years away. For those struggling with ongoing injuries and the medical costs associated with them, it is likely to feel like the litigation will never be resolved.

Applying for a transvaginal mesh settlement loan

For individuals in this situation, a transvaginal mesh settlement loan may be the answer. These non-recourse loans provide you with the money you need right now, rather than making you wait for the litigation process to move ahead. Funding is based on the jury award or settlement you are expected to receive, so there is no worry about coming up with collateral or going through a lengthy application process. No money is due until you win or settle your case.

At Lawstreet Capital, we understand how difficult it can be to wait for the legal process to run its course. We offer easy applications and fast approval to help you get the money you need to pay your bills now. Whether you need money for medical bills or to make up for lost wages while you were out of work, we can help.

Call us today at 1.866.FUND.662 for a confidential chat with a member of our team.